Webinar – Activating Pyruvate Kinase in Thalassemia: A Preclinical-to-Clinical Story of Mitapivat

We are pleased to host a webinar presented by Leonardo Rivadeneira, associate director, translational medicine, at Agios Pharmaceuticals.

Mitapivat, a first-in-class pyruvate kinase activator, has emerged as a promising therapeutic approach for thalassemia. This webinar will explore the scientific journey of Mitapivat, from its preclinical foundations to its clinical development, highlighting the biological rationale, key findings, and future perspectives of pyruvate kinase activation in thalassemia.

The session will provide researchers, clinicians, healthcare professionals, patients, and other stakeholders with the opportunity to learn directly from experts involved in the development of innovative therapies for hemoglobinopathies.

Speaker: Leonardo Rivadeneira, Agios Pharmaceuticals
Date: 29 June 2026
Time: 14:00 CEST
Link: https://teams.microsoft.com/meet/392992720261830?p=47JbR7yCdSn6XgiAPa